Literature DB >> 8267693

Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasis.

P Gilleaudeau1, V P Vallat, D M Carter, A B Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8267693     DOI： 10.1016/s0190-9622(08)81761-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.

Authors:  K L Goa; J A Balfour; G Zuanetti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 2.  Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature.

Authors:  Brahim Azzouz; Aurore Morel; Lukshe Kanagaratnam; Emmanuelle Herlem; Thierry Trenque
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

3.  [Trigger factors for psoriasis].

Authors:  H M Ockenfels
Journal:  Hautarzt       Date:  2003-02-21       Impact factor: 0.751

4.  B1 and B2 kinin receptor blockade improves psoriasis-like disease.

Authors:  Bruna da Silva Soley; Leonardo Martins Silva; Daniel Augusto Gasparin Bueno Mendes; André Báfica; João Bosco Pesquero; Michael Bader; Deborah A Witherden; Wendy L Havran; João B Calixto; Michel Fleith Otuki; Daniela Almeida Cabrini
Journal:  Br J Pharmacol       Date:  2020-05-30       Impact factor: 8.739

5.  A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence.

Authors:  Gonjin Song; Ji Yea Kim; Ha Young Yoon; Jeong Yee; Hye Sun Gwak
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.